GlycoNex Incorporation Total Liabilities

GlycoNex Incorporation (4168.TWO) currently reports a total liabilities of $540M as of June 2026. That compares with $280M in the prior-year period — up 91.9% year over year. Use the charts on this page to explore GlycoNex Incorporation's total liabilities history and peer comparisons.

GlycoNex Incorporation's total liabilities increased from $280M to $540M — a 91.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GlycoNex Incorporation reported $540M in total liabilities as of June 2026. That compares with $280M in the prior-year period — up 91.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $540M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GlycoNex Incorporation, and consider following 4168.TWO for alerts when major investors trade the stock.

GlycoNex Incorporation is classified in the Healthcare sector. On total liabilities, it currently shows $540M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 4168.TWO with unrelated industries.